This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
-
Anaheim Clinical Trials, LLC, Anaheim, California, United States, 92801
Diablo Clinical Research, Inc., Walnut Creek, California, United States, 94598
Miami Eye Institute, Hollywood, Florida, United States, 33024
Research Centers of America ( Hollywood ), Hollywood, Florida, United States, 33024
Research Centers of America, Hollywood, Florida, United States, 33024
CTI Clinical Research Center, Cincinnati, Ohio, United States, 45212
Senders Pediatrics, South Euclid, Ohio, United States, 44121
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States, 37909
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States, 37920
University Eye Specialists, P.C. (Ophthalmologist), Maryville, Tennessee, United States, 37803
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 64 Years
ALL
Yes
Pfizer,
Pfizer CT.gov Call Center, STUDY_DIRECTOR, Pfizer
2028-05-25